Wilkins Investment Counsel’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.64M Buy
113,069
+1,160
+1% +$103K 1.38% 27
2025
Q4
$8.84M Buy
111,909
+2,570
+2% +$201K 1.29% 27
2025
Q3
$8.74M Buy
109,339
+1,350
+1% +$115K 1.24% 33
2025
Q2
$9.82M Buy
107,989
+750
+0.7% +$68.5K 1.39% 31
2025
Q1
$10M Sell
107,239
-150
-0.1% -$13.4K 1.44% 30
2024
Q4
$9.76M Sell
107,389
-450
-0.4% -$42.9K 1.41% 29
2024
Q3
$11.2M Sell
107,839
-485
-0.4% -$49.4K 1.55% 28
2024
Q2
$10.5M Buy
108,324
+1,084
+1% +$100K 1.57% 29
2024
Q1
$9.66M Buy
107,240
+33,580
+46% +$2.85M 1.41% 28
2023
Q4
$5.87M Sell
73,660
-235
-0.3% -$17.7K 1.43% 32
2023
Q3
$5.25M Buy
73,895
+75
+0.1% +$5.61K 1.42% 30
2023
Q2
$5.69M Sell
73,820
-67
-0.1% -$5.19K 1.49% 32
2023
Q1
$5.55M Buy
73,887
+1,467
+2% +$109K 1.46% 33
2022
Q4
$5.71M Hold
72,420
1.5% 32
2022
Q3
$5.09M Sell
72,420
-325
-0.4% -$25.5K 1.49% 32
2022
Q2
$5.83M Sell
72,745
-3,200
-4% -$250K 1.55% 30
2022
Q1
$5.76M Sell
75,945
-325
-0.4% -$25.7K 1.3% 36
2021
Q4
$6.51M Buy
76,270
+1,065
+1% +$83.2K 1.44% 35
2021
Q3
$5.68M Sell
75,205
-45
-0.1% -$3.57K 1.39% 32
2021
Q2
$6.12M Buy
75,250
+1,050
+1% +$85.9K 1.51% 30
2021
Q1
$5.85M Buy
74,200
+8,510
+13% +$667K 1.51% 30
2020
Q4
$5.62M Hold
65,690
1.55% 29
2020
Q3
$5.07M Buy
65,690
+1,318
+2% +$100K 1.51% 29
2020
Q2
$4.72M Hold
64,372
1.49% 28
2020
Q1
$4.27M Buy
64,372
+1,072
+2% +$75.6K 1.56% 25
2019
Q4
$4.36M Buy
63,300
+600
+1% +$40.9K 1.24% 30
2019
Q3
$4.61M Sell
62,700
-800
-1% -$58K 1.39% 29
2019
Q2
$4.55M Hold
63,500
1.37% 31
2019
Q1
$4.35M Sell
63,500
-950
-1% -$61.4K 1.31% 31
2018
Q4
$3.84M Sell
64,450
-300
-0.5% -$18.8K 1.27% 31
2018
Q3
$4.33M Hold
64,750
1.3% 33
2018
Q2
$4.2M Sell
64,750
-400
-0.6% -$26.2K 1.32% 32
2018
Q1
$4.67M Sell
65,150
-1,000
-2% -$72K 1.48% 29
2017
Q4
$4.99M Sell
66,150
-1,900
-3% -$139K 1.49% 28
2017
Q3
$4.96M Sell
68,050
-2,800
-4% -$202K 1.51% 28
2017
Q2
$5.25M Sell
70,850
-3,050
-4% -$226K 1.67% 28
2017
Q1
$5.41M Hold
73,900
1.73% 29
2016
Q4
$4.84M Sell
73,900
-580
-0.8% -$39.8K 1.54% 32
2016
Q3
$5.52M Sell
74,480
-270
-0.4% -$20K 1.85% 28
2016
Q2
$5.47M Hold
74,750
1.85% 27
2016
Q1
$5.28M Buy
74,750
+300
+0.4% +$20K 1.94% 28
2015
Q4
$4.96M Sell
74,450
-3,550
-5% -$236K 1.86% 26
2015
Q3
$4.95M Sell
78,000
-610
-0.8% -$39.9K 1.89% 26
2015
Q2
$5.14M Sell
78,610
-800
-1% -$54.3K 1.87% 26
2015
Q1
$5.51M Sell
79,410
-300
-0.4% -$20.7K 1.95% 26
2014
Q4
$5.51M Sell
79,710
-250
-0.3% -$16.9K 1.92% 26
2014
Q3
$5.21M Sell
79,960
-750
-0.9% -$49.5K 1.86% 27
2014
Q2
$5.5M Sell
80,710
-1,100
-1% -$73.7K 1.94% 27
2014
Q1
$5.31M Sell
81,810
-2,050
-2% -$129K 1.96% 26
2013
Q4
$5.47M Sell
83,860
-1,880
-2% -$120K 2.27% 22
2013
Q3
$5.08M Sell
85,740
-100
-0.1% -$5.92K 2.32% 22
2013
Q2
$4.92M Buy
+85,840
New +$5.1M 2.28% 23

Other funds holding CL

Wilkins Investment Counsel's CL Position: Q1 2026 in Review

Wilkins Investment Counsel increased its Colgate-Palmolive (CL) stake by 1% in Q1 2026, buying an estimated $103K and bringing the position to 113,069 shares worth $9.64M. The position accounts for 1.38% of the portfolio, ranked #27.

Wilkins Investment Counsel first reported a position in CL in Q2 2013 and has held it in 52 quarters since. The position peaked at $11.2M in Q3 2024. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Wilkins Investment Counsel held 113,069 shares of Colgate-Palmolive worth $9.64M as of Q1 2026.
  • Wilkins Investment Counsel bought 1,160 Colgate-Palmolive shares in Q1 2026, an estimated $103K.
  • Colgate-Palmolive made up 1.38% of Wilkins Investment Counsel's portfolio in Q1 2026, its #27 holding.
  • Wilkins Investment Counsel first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 52 quarters since.
  • Wilkins Investment Counsel's Colgate-Palmolive position peaked at $11.2M in Q3 2024.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Wilkins Investment Counsel's 13F filing for Q1 2026, filed 7 May 2026.